Improvement of Lipoprotein Lipid Composition in Type II Diabetic Patients With Concomitant Hyperlipoproteinemia by Acipimox Treatment: Results of a multicenter trial

Abstract
Objective— To study the tolerability and efficacy of acipimox on hyperlipidemia and diabetes compensation in patients with NIDDM under conditions of a routine clinical practice.

This publication has 0 references indexed in Scilit: